Methods Assessed for Detecting Asymptomatic Malaria
|
By LabMedica International staff writers Posted on 03 May 2017 |

Image: The ABI 7500 Fast Dx real-time PCR instrument (Photo courtesy of Applied Biosystems).
Asymptomatic malaria infection refers to malarial parasitemia of any density in the absence of fever or other acute symptoms in individuals who have not received recent antimalarial treatments.
Sensitive methods for detecting asymptomatic malaria infections are essential for identifying potential transmission reservoirs and obtaining an accurate assessment of malaria epidemiology in low-endemicity areas aiming to eliminate malaria. Polymerase chain reaction (PCR) techniques to detect parasite nucleic acids (DNA or RNA) are among the most commonly used molecular methods.
Scientists at China Medical University and their colleagues recruited 1,005 healthy individuals (344 males and 661 females, ages 1–82 years) living in Kachin Sate, Myanmar between May and November, 2015. Two fingerprick samples were taken, one was processed in a nearby field laboratory, and the other on filter paper, dried and stored. The study compared three molecular detection methods side-by-side, namely nested PCR targeting the ribosomal ribonucleic acid (rRNA) genes, nested RT-PCR to detect parasite rRNA, and capture and ligation probe-PCR (CLIP-PCR) to detect parasite RNA.
Thick and thin blood films stained with Giemsa were prepared and read. For positive slides, parasite density was quantified in 500 white blood cells (WBCs) on thick blood films assuming that 1 µL of blood contains 8,000 WBCs. Total RNA and genomic DNA were extracted from peripheral blood samples. Modified nested PCR (nD-PCR) was performed based on the 18S rRNA gene. For the CLIP-PCR 3-mm circle of dried blood spot on 3 M Whatman filter paper was punched out and lysed with 100-µL lysis mixture. Two RT-PCR methods were used to detect Plasmodium vivax gametocytes in samples. For detection of P. vivax gametocytes in all 1,005 samples, the 645 bp full-length Pvs25 gene was amplified using Pvs25-specific primers. Amplification and detection were performed on an ABI 7500 apparatus.
Light microscopy detected Plasmodium infections in only 1.19% of the residents harboring the parasites. CLIP-PCR had slightly better performance and detected Plasmodium infections in 1.89% of the population. Further improvement was achieved by nested PCR to detect parasite DNA, which detected P. vivax and P. falciparum infections in 2.39% of the residents. The nested RT-PCR targeting rRNA, however, detected as many as 187 (18.61%) individuals having Plasmodium infections with P. vivax being the predominant species (176 P. vivax, five P. falciparum and six P. falciparum/P. vivax mixed infections). Of the 210 Plasmodium-positive samples detected by all molecular methods, 115 were Pvs25-positive by quantitative polymerase chain reaction (qRT-PCR), indicating that a large proportion of asymptomatic individuals were gametocyte carriers.
The authors concluded that Nested RT-PCR based on the detection of asexual-stage parasite rRNA was the most sensitive, with a more than six-fold higher sensitivity than the other two molecular methods of parasite detection. CLIP-PCR has an increased throughput, but its sensitivity in this study was much lower than those of other molecular methods. The study was published on April 20, 2017, in the Malaria Journal.
Sensitive methods for detecting asymptomatic malaria infections are essential for identifying potential transmission reservoirs and obtaining an accurate assessment of malaria epidemiology in low-endemicity areas aiming to eliminate malaria. Polymerase chain reaction (PCR) techniques to detect parasite nucleic acids (DNA or RNA) are among the most commonly used molecular methods.
Scientists at China Medical University and their colleagues recruited 1,005 healthy individuals (344 males and 661 females, ages 1–82 years) living in Kachin Sate, Myanmar between May and November, 2015. Two fingerprick samples were taken, one was processed in a nearby field laboratory, and the other on filter paper, dried and stored. The study compared three molecular detection methods side-by-side, namely nested PCR targeting the ribosomal ribonucleic acid (rRNA) genes, nested RT-PCR to detect parasite rRNA, and capture and ligation probe-PCR (CLIP-PCR) to detect parasite RNA.
Thick and thin blood films stained with Giemsa were prepared and read. For positive slides, parasite density was quantified in 500 white blood cells (WBCs) on thick blood films assuming that 1 µL of blood contains 8,000 WBCs. Total RNA and genomic DNA were extracted from peripheral blood samples. Modified nested PCR (nD-PCR) was performed based on the 18S rRNA gene. For the CLIP-PCR 3-mm circle of dried blood spot on 3 M Whatman filter paper was punched out and lysed with 100-µL lysis mixture. Two RT-PCR methods were used to detect Plasmodium vivax gametocytes in samples. For detection of P. vivax gametocytes in all 1,005 samples, the 645 bp full-length Pvs25 gene was amplified using Pvs25-specific primers. Amplification and detection were performed on an ABI 7500 apparatus.
Light microscopy detected Plasmodium infections in only 1.19% of the residents harboring the parasites. CLIP-PCR had slightly better performance and detected Plasmodium infections in 1.89% of the population. Further improvement was achieved by nested PCR to detect parasite DNA, which detected P. vivax and P. falciparum infections in 2.39% of the residents. The nested RT-PCR targeting rRNA, however, detected as many as 187 (18.61%) individuals having Plasmodium infections with P. vivax being the predominant species (176 P. vivax, five P. falciparum and six P. falciparum/P. vivax mixed infections). Of the 210 Plasmodium-positive samples detected by all molecular methods, 115 were Pvs25-positive by quantitative polymerase chain reaction (qRT-PCR), indicating that a large proportion of asymptomatic individuals were gametocyte carriers.
The authors concluded that Nested RT-PCR based on the detection of asexual-stage parasite rRNA was the most sensitive, with a more than six-fold higher sensitivity than the other two molecular methods of parasite detection. CLIP-PCR has an increased throughput, but its sensitivity in this study was much lower than those of other molecular methods. The study was published on April 20, 2017, in the Malaria Journal.
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







